Coles N Anthony 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2022/12/30 申報
- 申報編號
- 0001883850-22-000143
- 申報時間
- 2022/12/30
- 交易日
- 2022/12/28
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $411.2 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Coles N AnthonyCIK 0001197018 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/28 | Common Stock | M行使選擇權取得 | +2,145 | $374.12 | +$802,487.4 | 3,238 | 直接 | |
| 2022/12/28 | Common Stock | M行使選擇權取得 | +3,613 | $482.68 | +$1,743,922.84 | 6,851 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −181 | $707.87 | −$128,124.47 | 6,670 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −1 | $709.92 | −$709.92 | 6,669 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −679 | $710.63F2 | −$482,517.77 | 5,990 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −100 | $711.95 | −$71,195 | 5,890 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −1,198 | $713.66F3 | −$854,964.68 | 4,692 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −1,022 | $714.61F4 | −$730,331.42 | 3,670 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −2,266 | $715.48F5 | −$1,621,277.68 | 1,404 | 直接 | |
| 2022/12/28 | Common Stock | S賣出處分 | −311 | $716.08F6 | −$222,700.88 | 1,093 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/28 | Common Stock | M行使選擇權處分 | −2,145 | $0.00 | $0 | 0 | 直接 | |
| 2022/12/28 | Common Stock | M行使選擇權處分 | −3,613 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 679 shares of Company stock on December 28, 2022 at prices ranging from $710.48 to $710.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 1,198 shares of Company stock on December 28, 2022 at prices ranging from $713.17 to $713.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 1,022 shares of Company stock on December 28, 2022 at prices ranging from $714.00 to $714.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 2,266 shares of Company stock on December 28, 2022 at prices ranging from $715.04 to $715.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 311 shares of Company stock on December 28, 2022 at prices ranging from $716.02 to $716.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。